Both GlaxoSmithKline and Aviva are trading at low earnings multiples and have attractive dividend yields. But, as with all things in investing, there are risks to consider.
The Warren Buffett letters offer a lot of investing advice. I've used that advice to assess this UK share. I've spent years reading the Warren Buffett letters. Here's a UK share I'd pick based on Buffett's approach.